Advertisement

WHO to temporarily stop study of malaria drug

A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. Photo: AP/ Rafiq Maqbool. A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020.

The Associated Press
Updated: May 25, 2020 12:05 PM
Created: May 25, 2020 11:59 AM

The World Health Organization said that it will temporarily drop hydroxychloroquine — the malaria drug U.S. President Trump said he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.

In a news briefing on Monday, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet, that showed people taking hydroxychloroquine were at higher risk of death and heart problems than those who were not, there would be “a temporary pause” on the hydroxychloroquine arm of its global clinical trial.

Advertisement
Comment on Facebook
Advertisement

Pregnant woman dies, baby delivered after shooting in Minneapolis

CAIR-MN condemns Islamophobic incident at Midway Starbucks, calls for employees to be fired

MDH reports 434 new COVID-19 cases, 3 additional deaths

Country rocker and fiddler Charlie Daniels dies at age 83

Girl sexually assaulted at Powderhorn Park, suspect in custody

Judge orders Dakota Access pipeline shut down pending review

Advertisement